Skip to content
TheBrief.Health

Living with PD-L1-positive cancer

Stories from people navigating PD-L1-positive cancer — diagnosis, treatment, caregiving, and the ordinary days in between.

1 story

Lung cancer pathology slide beside immunotherapy and antibody-drug conjugate infusion bags

Oncology

Sacituzumab Tirumotecan Improves PFS in Advanced NSCLC

Interim phase 3 results favor adding sacituzumab tirumotecan to first-line pembrolizumab for PD-L1-positive advanced NSCLC, but survival, safety and generalizability remain unsettled.

Rayan Salih · September 16, 2026 · 6 min

Other conditions

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.